Sun Pharmaceutical Industries Navigates Mixed Market Trends Amidst Historical Growth
Sun Pharmaceutical Industries is trading at Rs 1693.45, with a market capitalization of Rs 4,03,196.25 crore. The stock's performance shows mixed trends against its moving averages. Over the past year, it has returned 7.26%, outperforming the Sensex, but has faced a year-to-date decline of 10.83%.
Sun Pharmaceutical Industries has shown notable activity today, trading at Rs 1693.45, consistent with its sector performance. The stock's current price is higher than its 20-day and 50-day moving averages, yet it remains below the 5-day, 100-day, and 200-day moving averages, indicating mixed short- to long-term trends.With a market capitalization of Rs 4,03,196.25 crore, Sun Pharmaceutical operates within the Pharmaceuticals & Biotechnology industry, where it holds a P/E ratio of 35.49, significantly lower than the industry average of 55.09.
In terms of performance metrics, Sun Pharmaceutical's one-year return stands at 7.26%, outperforming the Sensex, which has returned 1.47% over the same period. However, the stock has faced challenges recently, with a year-to-date decline of 10.83%, contrasting with the Sensex's gain of 4.67%. Over the last three years, the stock has appreciated by 93.29%, while the Sensex has increased by 46.89%.
Overall, Sun Pharmaceutical Industries continues to navigate a complex market landscape, reflecting both its historical growth and current performance challenges.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
